<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017128"><a href="http://purl.obolibrary.org/obo/MONDO_0017128">MONDO:0017128</a></h3>
<p><strong>Label:</strong> genetic digestive tract tumor</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018653">MONDO:0018653</a> (Polymerase proofreading-related adenomatous polyposis), <a href="http://purl.obolibrary.org/obo/MONDO_0008021">MONDO:0008021</a> (Cowden syndrome 1), <a href="http://purl.obolibrary.org/obo/MONDO_0018630">MONDO:0018630</a> (hereditary nonpolyposis colon cancer), <a href="http://purl.obolibrary.org/obo/MONDO_0016063">MONDO:0016063</a> (Cowden disease), <a href="http://purl.obolibrary.org/obo/MONDO_0008279">MONDO:0008279</a> (familial adenomatous polyposis type 1), <a href="http://purl.obolibrary.org/obo/MONDO_0016362">MONDO:0016362</a> (attenuated familial adenomatous polyposis), <a href="http://purl.obolibrary.org/obo/MONDO_0005835">MONDO:0005835</a> (Lynch syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0008280">MONDO:0008280</a> (Peutz-Jeghers syndrome),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_144">Orphanet:144</a>, <a href="http://www.orpha.net/ORDO/Orphanet_201">Orphanet:201</a>, <a href="http://purl.obolibrary.org/obo/OMIM_158350">OMIM:158350</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615083">OMIM:615083</a>, <a href="http://www.orpha.net/ORDO/Orphanet_65285">Orphanet:65285</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614350">OMIM:614350</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612591">OMIM:612591</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614331">OMIM:614331</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613244">OMIM:613244</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615107">OMIM:615107</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614337">OMIM:614337</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615108">OMIM:615108</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2869">Orphanet:2869</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616415">OMIM:616415</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2969">Orphanet:2969</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615106">OMIM:615106</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612359">OMIM:612359</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615109">OMIM:615109</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616858">OMIM:616858</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609310">OMIM:609310</a>, <a href="http://www.orpha.net/ORDO/Orphanet_733">Orphanet:733</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614385">OMIM:614385</a>, <a href="http://www.orpha.net/ORDO/Orphanet_443909">Orphanet:443909</a>, <a href="http://purl.obolibrary.org/obo/OMIM_175200">OMIM:175200</a>, <a href="http://purl.obolibrary.org/obo/OMIM_175100">OMIM:175100</a>, <a href="http://www.orpha.net/ORDO/Orphanet_220460">Orphanet:220460</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99818">Orphanet:99818</a>, <a href="http://purl.obolibrary.org/obo/OMIM_120435">OMIM:120435</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608456">OMIM:608456</a>, <a href="http://www.orpha.net/ORDO/Orphanet_247806">Orphanet:247806</a>, <a href="http://www.orpha.net/ORDO/Orphanet_447877">Orphanet:447877</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79665">Orphanet:79665</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 50.95%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm))) 49.01%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0003003">HP:0003003</a> (Colon cancer))) 49.01%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002665">HP:0002665</a> (Lymphoma))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100013">HP:0100013</a> (Neoplasm of the breast) 47.25%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100787">HP:0100787</a> (Prostate neoplasm))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100641">HP:0100641</a> (Neoplasm of the adrenal cortex))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100631">HP:0100631</a> (Neoplasm of the adrenal gland))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100615">HP:0100615</a> (Ovarian neoplasm))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012125">HP:0012125</a> (Prostate cancer))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011732">HP:0011732</a> (Abnormality of adrenal morphology))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010622">HP:0010622</a> (Neoplasm of the skeletal system))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0008775">HP:0008775</a> (Abnormality of the prostate))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002669">HP:0002669</a> (Osteosarcoma))) 46.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000834">HP:0000834</a> (Abnormality of the adrenal glands))) 46.80%</li>
</ul>
</body>
</html>
